A Comprehensive Analysis of the Management of Brain Metastases—Experience from a South-Eastern European Neurosurgical Centre
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Design and Setting
2.2. Participants
- Were aged 18 years or older;
- Had a histologically confirmed brain metastasis;
- Underwent surgical resection (gross total or subtotal);
- Had complete demographic, operative, and follow-up records available.
- Had incomplete surgical data;
- Had surgery for a non-metastatic brain lesion;
- Underwent biopsy only or radiosurgery without open resection.
2.3. Data Collection and Variables
- Sex, age, corrected age;
- Number and location of brain metastases;
- Eloquent zone involvement;
- Primary tumour type and status (known/unknown at brain metastasis diagnosis);
- Extracranial metastases (present or absent);
- Karnofsky Performance Status (KPS) (>70 vs. ≤70);
- Postoperative complications;
- Comorbidity count and classification (categorised into 0 to 6+);
- Recurrence count and time intervals;
- Extent of resection (GTR vs. STR);
- Postoperative mortality (in hospital).
2.4. Surgical Procedure and Classification
- Gross total resection (GTR): no residual enhancing tumour.
- Subtotal resection (STR): residual enhancing tumour present.
2.5. Postoperative Management
- Postoperative complications (neurological or systemic within 30 days);
- Recurrence (local radiographic recurrence at the resection site);
- Functional status, measured using KPS, categorised as >70 vs. ≤70;
- Mortality;
- Overall survival (OS) was defined as the interval between the date of neurosurgical resection and the date of death from any cause or the last known follow-up for censored patients;
- Recurrence intervals (1–6, 7–12, 13–26, ≥27 months).
2.6. Vital Status Confirmation
2.7. Statistical Analysis
2.8. Survival Analysis
3. Results
3.1. Patient Characteristics
3.2. Age Comparisons Across Clinical Subgroups (Mann–Whitney U Tests)
3.3. Associations Among Categorical Variables (Chi-Square Test)
3.4. Additional Significant Associations
3.5. Survival Analysis
3.6. Gross Total Resection and Mortality
3.7. Binary Logistic Regression Analysis
4. Discussion
4.1. Overall Survival (OS)
4.2. Recurrence
4.3. Complications and Surgical Risk
4.4. Prognostic Factors
4.5. Adjunct Therapies and Multimodal Management
4.6. Particularities of the Study
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
Abbreviation | Full Term |
BM | Brain Metastasis |
GTR | Gross Total Resection |
STR | Subtotal Resection |
KPS | Karnofsky Performance Status |
WBRT | Whole-Brain Radiotherapy |
SRS | Stereotactic Radiosurgery |
OS | Overall Survival |
PFS | Progression-Free Survival |
OR | Odds Ratio |
CI | Confidence Interval |
MRI | Magnetic Resonance Imaging |
ICU | Intensive Care Unit |
CT | Computed Tomography |
References
- Sacks, P.; Rahman, M. Epidemiology of Brain Metastases. Neurosurg. Clin. N. Am. 2020, 31, 481–488. [Google Scholar] [CrossRef] [PubMed]
- Han, Y.; Ou, D.; Chai, W.; Yang, W.; Liu, Y.; Xiao, J.; Zhang, W.; Qi, W.; Chen, J. Exploration of Anatomical Distribution of Brain Metastasis from Breast Cancer at First Diagnosis Assisted by Artificial Intelligence. Heliyon 2024, 10, e29350. [Google Scholar] [CrossRef]
- Fisher, R.S.; Kenney, A.E.; Fults, M.Z.; Manring, S.; Rodriguez, E.M.; Desjardins, L.; Rausch, J.R.; Young-Saleme, T.; Ranalli, M.A.; Vannatta, K.; et al. Longitudinal Understanding of Prognosis among Adolescents with Cancer. Pediatr. Blood Cancer 2021, 68, e28826. [Google Scholar] [CrossRef] [PubMed]
- Stone, P.; Buckle, P.; Dolan, R.; Feliu, J.; Hui, D.; Laird, B.J.A.; Maltoni, M.; Moine, S.; Morita, T.; Nabal, M.; et al. Prognostic Evaluation in Patients with Advanced Cancer in the Last Months of Life: ESMO Clinical Practice Guideline. ESMO Open 2023, 8, 101195. [Google Scholar] [CrossRef] [PubMed]
- Patchell, R.A. The Treatment of Brain Metastases. Cancer Investig. 1996, 14, 169–177. [Google Scholar] [CrossRef]
- Das, J.M. Metastatic Brain Tumors. In Neuro-Oncology Explained Through Multiple Choice Questions; Springer: Berlin/Heidelberg, Germany, 2023; pp. 133–137. ISBN 9783031132537. [Google Scholar]
- Winther, R.R.; Hjermstad, M.J.; Skovlund, E.; Aass, N.; Helseth, E.; Kaasa, S.; Yri, O.E.; Vik-Mo, E.O. Surgery for Brain Metastases—Impact of the Extent of Resection. Acta Neurochir. 2022, 164, 2773–2780. [Google Scholar] [CrossRef]
- Phillips, W.J.; Baghai, T.; Ong, M.; Lo, B.; Ibrahim, A.M.; Smith, T.K.T.; Song, X. A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases. Curr. Oncol. 2021, 28, 428–439. [Google Scholar] [CrossRef]
- Gusho, C.A.; Blank, A.T.; Batus, M. Outcomes of Brain Metastasis in High-Grade Bone and Soft Tissue Sarcoma: An Analysis of Clinicopathological Characteristics and Survival Data. Rare Tumors 2021, 13. [Google Scholar] [CrossRef]
- Liu, Z.; Lei, B.; Zheng, M.; Li, Z.; Huang, S.; Deng, Y. Prognostic Factors in Patients Treated with Surgery for Brain Metastases: A Single-Center Retrospective Analysis of 125 Patients. Int. J. Surg. 2017, 44, 204–209. [Google Scholar] [CrossRef]
- Kavouridis, V.K.; Harary, M.; Hulsbergen, A.F.C.; Lo, Y.T.; Reardon, D.A.; Aizer, A.A.; Iorgulescu, J.B.; Smith, T.R. Survival and Prognostic Factors in Surgically Treated Brain Metastases. J. Neuro-Oncol. 2019, 143, 359–367. [Google Scholar] [CrossRef]
- Hulsbergen, A.F.C.; Lo, Y.T.; Awakimjan, I.; Kavouridis, V.K.; Phillips, J.G.; Smith, T.R.; Verhoeff, J.J.C.; Yu, K.H.; Broekman, M.L.D.; Arnaout, O. Survival Prediction After Neurosurgical Resection of Brain Metastases: A Machine Learning Approach. Neurosurgery 2022, 91, 381–388. [Google Scholar] [CrossRef]
- Proescholdt, M.A.; Schödel, P.; Doenitz, C.; Pukrop, T.; Höhne, J.; Schmidt, N.O.; Schebesch, K.M. The Management of Brain Metastases—Systematic Review of Neurosurgical Aspects. Cancers 2021, 13, 1616. [Google Scholar] [CrossRef]
- Yardeni, D.; Reichenthal, E.; Zucker, G.; Rubeinstein, A.; Cohen, M.; Israeli, J.; Shalit, M.N. Neurosurgical Management of Single Brain Metastasis. Surg. Neurol. 1984, 21, 377–384. [Google Scholar] [CrossRef] [PubMed]
- Tabouret, E.; Chinot, O.; Metellus, P.; Tallet, A.; Viens, P.; Gonçalves, A. Recent Trends in Epidemiology of Brain Metastases: An Overview. Anticancer. Res. 2012, 32, 4655–4662. [Google Scholar] [PubMed]
- Dasgupta, A.; Co, J.; Winter, J.; Millar, B.A.; Laperriere, N.; Tsang, D.S.; van Prooijen, M.; Damyanovich, A.; Heaton, R.; Coolens, C.; et al. Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis Patients. Curr. Oncol. 2021, 28, 549–559. [Google Scholar] [CrossRef]
- Michel, A.; Oppong, M.D.; Rauschenbach, L.; Dinger, T.F.; Barthel, L.; Pierscianek, D.; Wrede, K.H.; Hense, J.; Pöttgen, C.; Junker, A.; et al. Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases. Cancers 2022, 14, 1437. [Google Scholar] [CrossRef] [PubMed]
- Hügel, M.; Stöhr, J.; Kuhnt, T.; Nägler, F.; Papsdorf, K.; Klagges, S.; Hambsch, P.; Güresir, E.; Nicolay, N.H.; Seidel, C. Long-Term Survival in Patients with Brain Metastases—Clinical Characterization of a Rare Scenario. Strahlenther. Onkol. 2024, 200, 335–345. [Google Scholar] [CrossRef]
- Ene, C.I.; Ferguson, S.D. Surgical Management of Brain Metastasis: Challenges and Nuances. Front. Oncol. 2022, 12, 847110. [Google Scholar] [CrossRef]
- Xu, M.; Song, K.; Zhou, Z.; Yu, Z.; Lv, Y.; Xu, H. Survival and Prognostic Factors in Patients Undergoing the Resection of Solitary Brain Metastasis from Non-Small Cell Lung Cancer: A Retrospective Cohort Study. J. Thorac. Dis. 2022, 14, 4113–4124. [Google Scholar] [CrossRef]
- Suh, J.H.; Kotecha, R.; Chao, S.T.; Ahluwalia, M.S.; Sahgal, A.; Chang, E.L. Current Approaches to the Management of Brain Metastases. Nat. Rev. Clin. Oncol. 2020, 17, 279–299. [Google Scholar] [CrossRef]
- Cuthbert, H.; Riley, M.; Bhatt, S.; Au-Yeung, C.; Tsermoulas, G.; Wykes, V.; Watts, C. Predicting Survival Following Surgery for Brain Metastases. Br. J. Neurosurg. 2023, 37, 564. [Google Scholar]
- Arita, H.; Ikawa, T.; Kanayama, N.; Morimoto, M.; Umehara, T.; Yoshizawa, H.; Kodama, Y.; Okita, Y.; Kinoshita, M.; Konishi, K. Prognostic Factors after Salvage Resection for Local Progression of Brain Metastases after Radiotherapy. Acta Neurochir. 2025, 167, 163. [Google Scholar] [CrossRef]
- Jędrys, W.; Leśniak, A.; Borkowska, A.; Rutkowski, P.; Sobczuk, P. Brain Metastases of Sarcoma: A Rare Phenomenon in Rare Tumours. J. Cancer Res. Clin. Oncol. 2023, 149, 18271–18281. [Google Scholar] [CrossRef]
- Liu, Q.; Tong, X.; Wang, J. Management of Brain Metastases: History and the Present. Chin. Neurosurg. J. 2019, 5, 1. [Google Scholar] [CrossRef] [PubMed]
- Pojskic, M.; Bopp, M.A.; Schymalla, M.; Nimsky, C.; Carl, B. Retrospective Study of 229 Surgically Treated Patients with Brain Metastases: Prognostic Factors, Outcome and Comparison of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment. Surg. Neurol. Int. 2017, 8, 259. [Google Scholar] [CrossRef] [PubMed]
Sex | N | Mean ± SD | Median (IQR) |
---|---|---|---|
Male | 191 | 65.8 ± 10.7 | 69 (59–73) |
Female | 167 | 60.1 ± 12.0 | 61 (52–69) |
Category | Characteristic | N | % |
---|---|---|---|
Sex | Male | 191 | 53.4% |
Female | 167 | 46.6% | |
KPS | KPS > 70 | 175 | 48.9% |
KPS < 70 | 183 | 51.1% | |
Tumour Characteristics | Primary tumour known | 209 | 58.4% |
Pulmonary primary | 166 | 46.4% | |
Breast cancer | 48 | 13.4% | |
Melanoma | 46 | 12.8% | |
Clear cell Renal cell carcinoma | 36 | 10.1% | |
Other | 62 | 17.3% | |
Brain Metastasis | Single brain metastasis | 313 | 87.4% |
Multiple metastases | 45 | 12.6% | |
Eloquent zone involvement | 193 | 53.9% | |
Non-eloquent zone | 165 | 46.1% | |
Frontal | 119 | 33.2% | |
Parietal | 64 | 17.9% | |
Cerebellum | 46 | 12.8% | |
Temporal | 35 | 9.8% | |
Multiple locations | 45 | 12.6% | |
Occipital | 26 | 7.3% | |
Brainstem | 8 | 2.2% | |
Sellar region | 4 | 1.1% | |
Insular | 4 | 1.1% | |
Basal ganglia | 4 | 1.1% | |
Thalamus | 3 | 0.8% | |
Clinical Course | Gross Total Resection | 336 | 93.9% |
Subtotal Resection | 22 | 6.1% | |
Complications | Postop complications | 72 | 20.1% |
No complications | 286 | 79.9% | |
Mortality | Mortality | 5 | 1.4% |
No mortality | 353 | 98.6% | |
Recurrence | Recurrence | 39 | 10.9% |
No recurrence | 319 | 89.1% | |
Comorbidities | No comorbidity | 165 | 46.1% |
1–6 comorbidities | 193 | 53.9% | |
Recurrence | 1–6 months | 23 | 6.4% |
7–12 months | 7 | 2.0% | |
13–26 months | 5 | 1.4% | |
<27 months | 1 | 0.3% |
Outcome | IPTW OR | 95% CI Lower | 95% CI Upper | p-Value |
---|---|---|---|---|
Postop complications | 0.59 | 0.17 | 2.03 | 0.402 |
Recurrence | 1.29 | 0.39 | 4.24 | 0.678 |
Postop mortality | 0.15 | 0.02 | 1.14 | 0.067 |
Outcome | Crude OR | 95% CI Lower | 95% CI Upper | p-Value |
---|---|---|---|---|
Postop complications | 0.68 | 0.32 | 1.45 | 0.317 |
Recurrence | 1.45 | 0.62 | 3.40 | 0.393 |
Postop mortality | 0.09 | 0.02 | 0.51 | 0.006 |
Variable | GTR (n = 336) | STR (n = 22) | p-Value |
---|---|---|---|
Age (years, median [IQR]) | 65.0 (55.8–71.0) | 68.5 (61.5–75.0) | 0.079 |
Male sex (%) | 53.0 | 59.1 | 0.737 |
KPS > 70 (%) | 48.2 | 59.1 | 0.442 |
Eloquent location (%) | 53.6 | 59.1 | 0.778 |
Number of brain metastases (median [IQR]) | 1.0 (1.0–1.0) | 1.0 (1.0–1.0) | 0.693 |
Comorbidity count (median [IQR]) | 1.0 (0.0–2.0) | 1.0 (0.0–2.0) | 0.845 |
Primary tumour known (%) | 58.0 | 68.2 | 0.337 |
Extracranial metastases (%) | 15.2 | 18.2 | 0.754 |
Time (Days) | All Patients |
---|---|
0 | 354 |
180 (6 mo) | 231 |
365 (12 mo) | 164 |
730 (24 mo) | 89 |
1095 (36 mo) | 43 |
Time (Days) | Male | Female |
---|---|---|
0 | 191 | 163 |
180 (6 mo) | 119 | 112 |
365 (12 mo) | 81 | 83 |
730 (24 mo) | 42 | 47 |
1095 (36 mo) | 22 | 21 |
Time (Days) | GTR | STR |
---|---|---|
0 | 332 | 22 |
180 (6 mo) | 216 | 15 |
365 (12 mo) | 152 | 12 |
730 (24 mo) | 80 | 9 |
1095 (36 mo) | 39 | 4 |
Time (Days) | No Recurrence | Once | Twice | 3 Times | 5 Times |
---|---|---|---|---|---|
0 | 316 | 26 | 9 | 3 | 0 |
180 (6 mo) | 195 | 24 | 9 | 3 | 0 |
365 (12 mo) | 142 | 14 | 6 | 2 | 0 |
730 (24 mo) | 74 | 5 | 4 | 1 | 0 |
1095 (36 mo) | 36 | 3 | 0 | 0 | 0 |
Variable | HR (95% CI) | p-Value |
---|---|---|
Extent of resection | 1.44 (1.08–1.93) | 0.013 |
Age at surgery (years) | 1.02 (1.01–1.03) | <0.001 |
Sex (male vs. female) | 1.17 (0.92–1.49) | 0.212 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tofan, F.A.; Massoud, A.T.; Faur, C.I.; Florian, I.Ș. A Comprehensive Analysis of the Management of Brain Metastases—Experience from a South-Eastern European Neurosurgical Centre. Medicina 2025, 61, 1773. https://doi.org/10.3390/medicina61101773
Tofan FA, Massoud AT, Faur CI, Florian IȘ. A Comprehensive Analysis of the Management of Brain Metastases—Experience from a South-Eastern European Neurosurgical Centre. Medicina. 2025; 61(10):1773. https://doi.org/10.3390/medicina61101773
Chicago/Turabian StyleTofan, Florin Adrian, Ahmed T. Massoud, Cosmin Ioan Faur, and Ioan Ștefan Florian. 2025. "A Comprehensive Analysis of the Management of Brain Metastases—Experience from a South-Eastern European Neurosurgical Centre" Medicina 61, no. 10: 1773. https://doi.org/10.3390/medicina61101773
APA StyleTofan, F. A., Massoud, A. T., Faur, C. I., & Florian, I. Ș. (2025). A Comprehensive Analysis of the Management of Brain Metastases—Experience from a South-Eastern European Neurosurgical Centre. Medicina, 61(10), 1773. https://doi.org/10.3390/medicina61101773